American Journal of Public Health, Vol 91, Issue 5 710-716, Copyright © 2001 by American Public Health Association

JOURNAL ARTICLE

Hospital preparedness for victims of chemical or biological terrorism

DC Wetter, WE Daniell and CD Treser

OBJECTIVES: This study examined hospital preparedness for incidents involving chemical or biological weapons. METHODS: By using a questionnaire survey of 224 hospital emergency departments in 4 northwestern states, we examined administrative plans, training, physical resources, and representative medication inventories. RESULTS: Responses were received from 186 emergency departments (83%). Fewer than 20% of respondent hospitals had plans for biological or chemical weapons incidents. About half (45%) had an indoor or outdoor decontamination unit with isolated ventilation, shower, and water containment systems, but only 12% had 1 or more self-contained breathing apparatuses or supplied air-line respirators. Only 6% had the minimum recommended physical resources for a hypothetical sarin incident. Of the hospitals providing quantitative answers about medication inventories, 64% reported sufficient ciprofloxacin or doxycycline for 50 hypothetical anthrax victims, and only 29% reported sufficient atropine for 50 hypothetical sarin victims (none had enough pralidoxime). CONCLUSIONS: Hospital emergency departments generally are not prepared in an organized fashion to treat victims of chemical or biological terrorism. The planned federal efforts to improve domestic preparedness will require substantial additional resources at the local level to be truly effective.

This article has been cited by other articles:

				N. Hupert, D. Wattson, J. Cuomo, E. Hollingsworth, K. Neukermans, and W. Xiong Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations Med Decis Making, July 1, 2009; 29(4): 424 - 437. [Abstract] [PDF]

				R. S. Braithwaite, D. Fridsma, and M. S. Roberts The Cost-Effectiveness of Strategies to Reduce Mortality from an Intentional Release of Aerosolized Anthrax Spores Med Decis Making, March 1, 2006; 26(2): 182 - 193. [Abstract] [PDF]

				S. W. Wiener and R. S. Hoffman Nerve Agents: A Comprehensive Review J Intensive Care Med, January 1, 2004; 19(1): 22 - 37. [Abstract] [PDF]

				E. Kahan, Y. Fogelman, E. Kitai, and S. Vinker Patient and family physician preferences for care and communication in the eventuality of anthrax terrorism Fam. Pract., August 1, 2003; 20(4): 441 - 442. [Abstract] [Full Text] [PDF]

				N. Hupert, A. I. Mushlin, and M. A. Callahan Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers Med Decis Making, October 1, 2002; 22(5_suppl): S17 - S25. [Abstract] [PDF]

				P. E. Marik and S. Bowles Analytic Reviews: Management of Patients Exposed to Biological and Chemical Warfare Agents J Intensive Care Med, July 1, 2002; 17(4): 147 - 161. [Abstract] [PDF]

				H. W. Cohen, V. W. Sidel, and R. M. Gould Preparedness for Bioterrorism? N. Engl. J. Med., November 8, 2001; 345(19): 1423 - 1424. [Full Text] [PDF]

				Are We Prepared for Chemical or Biological Terrorism? Journal Watch Emergency Medicine, May 30, 2001; 2001(530): 13 - 13. [Full Text]

eLetters: